Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.

Abramovitz M, Barwick BG, Willis S, Young B, Catzavelos C, Li Z, Kodani M, Tang W, Bouzyk M, Moreno CS, Leyland-Jones B.

Br J Cancer. 2011 Nov 8;105(10):1574-81. doi: 10.1038/bjc.2011.355.

PMID: 22067903 [PubMed – indexed for MEDLINE] Free PMC Article

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

AKESOgen at Bio-Europe 2011

AKESOgen scientists participated in the Bio-Europe 2011 Conference in Duesseldorf, Germany on October 31st-November 2nd 2011. Please email info@akesogen.com or call +1(770)542-0890 if you would like to follow up with an AKESOgen representative related to the conference.

Bio Europe 2011

 

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: analyzing material from the HC registry

Identification of candidate genes for histiocytoid cardiomyopathy (HC) using whole genome expression analysis: analyzing material from the HC registry.

Shehata BM, Bouzyk M, Shulman SC, Tang W, Steelman CK, Davis GK, Moreno CS.

Pediatr Dev Pathol. 2011 Sep-Oct;14(5):370-7. doi: 10.2350/10-05-0826-OA.1. Epub 2011 May 17.

PMID: 21585276 [PubMed – indexed for MEDLINE] Free PMC Article

 

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy

Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy.

Long Q, Johnson BA, Osunkoya AO, Lai YH, Zhou W, Abramovitz M, Xia M, Bouzyk MB, Nam RK, Sugar L, Stanimirovic A, Williams DJ, Leyland-Jones BR, Seth AK, Petros JA, Moreno CS.

Am J Pathol. 2011 Jul;179(1):46-54. doi: 10.1016/j.ajpath.2011.03.008. Epub 2011 May 3.

PMID: 21703393 [PubMed – indexed for MEDLINE] Free PMC Article

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

Dr. Hywel Jones appointed to Board of Directors.

AKESOgen, Inc. is pleased to announce that Dr. Hywel Jones has joined AKESOgen’s board of directors.  Mr. Jones is currently the President and CEO of Singular Bio, Inc.  Dr. Jones brings over 20 years of experience within the field of personalized medicine, molecular diagnostics, and platform technologies.  He currently resides in San Francisco, CA.

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies.

Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, Burnett MS, Devaney JM, Knouff CW, Thompson JR, Horne BD, Stewart AF, Assimes TL, Wild PS, Allayee H, Nitschke PL, Patel RS; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium, Martinelli N, Girelli D, Quyyumi AA, Anderson JL, Erdmann J, Hall AS, Schunkert H, Quertermous T, Blankenberg S, Hazen SL, Roberts R, Kathiresan S, Samani NJ, Epstein SE, Rader DJ.

Lancet. 2011 Jan 29;377(9763):383-92. doi: 10.1016/S0140-6736(10)61996-4. Epub 2011 Jan 14.

 

Share this Facebooktwittergoogle_plusredditlinkedinmailFacebooktwittergoogle_plusredditlinkedinmail